From Bench to Bedside
The New England Journal of Medicine publishes Matthew Smith, MD, PhD's study on bone density treatment for prostate cancer patients
The New England Journal of Medicine recently published the work of Matthew Smith, MD, PhD, on bone density treatment for men undergoing hormone deprivation therapy for prostate cancer. The report from an international research study with over 900 participants led by Smith, shows that a new therapy called denosumab cuts fracture risks for prostate cancer survivors. "The results of this study should be critically important in improving the quality of life of thousands of prostate cancer survivors," says Smith.
For more information: http://www.massgeneral.org/about/pressrelease.aspx?id=1157
Discover the Cancer Center patient experience 
Our approach to patient care unites cancer specialists across the hospital to create a personalized treatment plan for each patient, ensuring the best possible outcomes.
Search the Mass General news archive
Search the archive for previously published news articles, press releases and publications.
